Gencurix Publishes a Clinical Validation Study on GenesWell BCT, a New Breast Cancer Prognostic Test
SEOUL, South Korea--(BUSINESS WIRE)--On 28 March, Gencurix (KONEX:229000) announced that the results of clinical trials for the prediction of breast cancer prognosis were published in Scientific ...
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, ...
Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing Current guidelines for postoperative management of patients with stage I-IIA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback